← Back to all trials
Active Not Recruiting
NCT06854042
A Study of Oral E1018 in Healthy Adult Participants
Conditions: Malaria, Healthy Participants
Sex: All
Ages: 18 Years – 55 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 32
Sponsor: Eisai Inc.
Location: PPD Development, LP Austin Texas
Summary
The primary purpose of the study is to evaluate the safety and tolerability of single ascending oral doses of E1018 in healthy adult participants and to evaluate the pharmacokinetics (PK) of E1018 in plasma and urine after single oral dose administration.
Eligibility Criteria
Inclusion criteria:
1. Nonsmoking/vaping, male or female, age greater than or equal to (\>=) 18 years to less than or equal (\=18 and less than (\
Source: ClinicalTrials.gov (NCT06854042). StuddyBuddy aggregates publicly available trial information.
